|
82
|
304
|
9xyzA |
Crystal structure of sars-cov-2 main protease (mpro) e166v mutant |
|
82
|
305
|
9sdmA |
Crystal structure of sars-cov-2 main protease (mpro) in complex with the covalently bound inhibitor gue-4303 (compound 12 in publication) |
|
0
|
10
|
9lgqC |
The crystal structure of sars-cov-2 nsp5 in complex with ptbp1 |
|
84
|
306
|
9lgqA |
The crystal structure of sars-cov-2 nsp5 in complex with ptbp1 |
|
86
|
298
|
9m6rA |
Crystal structure of sars-cov-2 main protease e166n mutant in complex with pomotrelvir |
|
85
|
299
|
9m6vA |
Crystal structure of sars-cov-2 main protease v186f mutant in complex with pomotrelvir |
|
86
|
299
|
9m6uA |
Crystal structure of sars-cov-2 main protease m49i mutant in complex with pomotrelvir |
|
87
|
296
|
9m6tA |
Crystal structure of sars-cov-2 main protease h163a mutant in complex with pomotrelvir |
|
78
|
306
|
9zo3A |
X-ray structure of sars-cov-2 main protease covalently bound to inhibitor grl-062-22 at 1.65 a |
|
88
|
305
|
9pkrA |
Sars-cov2 main protease bound to compound 26 |
|
90
|
306
|
9znlA |
X-ray structure of sars-cov-2 main protease covalently bound to inhibitor grl-050-22 at 1.16 a |
|
85
|
306
|
9pjgA |
Sars-cov2 mpro bound to compound 1 |
|
74
|
300
|
9y8wA |
Mers mpro with egt710 |
|
86
|
305
|
9uoqA |
Crystal structure of sars-cov-2 3cl protease (3clpro) in complex with compound 8 |
|
87
|
305
|
9ir9A |
Sars-cov-2 3cl protease (3clpro) in complex with compound 6 |
|
84
|
306
|
9oixA |
Co-structure of main protease of sars-cov-2 with nvp-egt710 |
|
88
|
303
|
9o6eA |
Crystal structure of sars-cov-2 mpro s10c in complex with pfizer intravenous inhibitor pf-00835231 |
|
86
|
303
|
9opmA |
Crystal structure of sars-cov-2 mpro s147a in complex with pfizer intravenous inhibitor pf-00835231 |
|
86
|
303
|
9o6qA |
Crystal structure of sars-cov-2 mpro l115a in complex with pfizer intravenous inhibitor pf-00835231 |
|
85
|
303
|
9opnA |
Crystal structure of sars-cov-2 mpro s147n in complex with pfizer intravenous inhibitor pf-00835231 |
|
89
|
303
|
9o6dA |
Crystal structure of sars-cov-2 mpro s10a in complex with pfizer intravenous inhibitor pf-00835231 |
|
84
|
303
|
9o6fA |
Crystal structure of sars-cov-2 mpro s113a in complex with pfizer intravenous inhibitor pf-00835231 |
|
86
|
303
|
9o74A |
Crystal structure of sars-cov-2 mpro l115m in complex with pfizer intravenous inhibitor pf-00835231 |
|
81
|
303
|
9o6pA |
Crystal structure of sars-cov-2 mpro s113c in complex with pfizer intravenous inhibitor pf-00835231 |
|
91
|
306
|
9n6fA |
X-ray structure of sars-cov-2 main protease m165i covalently bound to inhibitor grl-051-22 at 1.90 a |
|
85
|
306
|
9nnwA |
X-ray structure of sars-cov-2 main protease v186f covalently bound to inhibitor grl-050-23 at 1.55 a |
|
77
|
306
|
9z74A |
X-ray structure of sars-cov-2 main protease v186g covalently bound to inhibitor nirmatrelvir at 1.81 a |
|
84
|
306
|
9e8rA |
X-ray structure of sars-cov-2 main protease t190i covalently bound to compound grl-051-22 at 1.5 a |
|
80
|
306
|
9e7bA |
X-ray structure of sars-cov-2 main protease v186g covalently bound to compound grl-051-22 at 1.3 a |
|
88
|
306
|
9e7sA |
X-ray structure of sars-cov-2 main protease covalently bound to compound grl-051-22 at 1.75 a. |
|
84
|
306
|
9mljA |
X-ray structure of sars-cov-2 main protease covalently bound to compound grl-050-23 at 1.6 a |
|
83
|
306
|
9n5qA |
X-ray structure of sars-cov-2 main protease m49i covalently bound to inhibitor grl-051-22 at 1.50 a |
|
90
|
306
|
9nngA |
X-ray structure of sars-cov-2 main protease v186i covalently bound to inhibitor grl-051-22 at 1.90 a |
|
89
|
306
|
9n9bA |
X-ray structure of sars-cov-2 main protease v186f covalently bound to inhibitor grl-051-22 at 1.60 a |
|
91
|
304
|
8zbpA |
The crystal structure of sars-cov-2 main protease in complex with chebulagic acid (chla) |
|
87
|
301
|
9nu6A |
Sars-cov-2 main protease with inhibitor |
|
74
|
301
|
9izbA |
Crystal structure of sars-cov-2 main protease in complex with tmp1 |
|
81
|
306
|
9bvzA |
Sars-cov-2 main protease bound to inhibitor ar-a-135 |
|
85
|
306
|
9bvxA |
Sars-cov-2 main protease bound to inhibitor yr-c-155 |
|
81
|
303
|
9du3A |
Sars-cov-2 mpro in complex with compound 1 |
|
83
|
301
|
9dtzA |
Sars-cov-2 mpro in complex with compound 5 |
|
86
|
301
|
9du2A |
Sars-cov-2 mpro in complex with compound 7 |
|
80
|
301
|
9du4A |
Sars-cov-2 mpro in complex with compound 3 |
|
80
|
305
|
9ksiA |
Crystal structure of sars-cov-2 main protease in complex with compound 5 |
|
86
|
301
|
9ksjA |
Crystal structure of sars-cov-2 main protease in complex with compound 8 |
|
80
|
301
|
9inmA |
Crystal structure of mers main protease in complex with bofutrelvir |
|
86
|
302
|
9kr5A |
Crystal structure of sars-cov-2 main protease in complex with compound 3 |
|
88
|
302
|
9kshA |
Crystal structure of sars-cov-2 main protease in complex with compound 1 |
|
85
|
303
|
9el4A |
Crystal structure of sars-cov-2 mpro mutant e166a with pfizer intravenous inhibitor pf-00835231 |
|
85
|
303
|
9elvA |
Crystal structure of sars-cov-2 mpro mutant e166v with pfizer intravenous inhibitor pf-00835231 |
